MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
56.42
-0.38
-0.67%
After Hours: 56.42 0 0.00% 19:58 07/14 EDT
OPEN
55.84
PREV CLOSE
56.80
HIGH
56.67
LOW
54.93
VOLUME
2.46M
TURNOVER
--
52 WEEK HIGH
63.68
52 WEEK LOW
30.04
MARKET CAP
4.87B
P/E (TTM)
-12.4939
1D
5D
1M
3M
1Y
5Y
1D
Is It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views?
NASDAQ · 11h ago
Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)
Seeking Alpha · 12h ago
Weekly Report: what happened at CRSP last week (0707-0711)?
Weekly Report · 14h ago
Crispr Therapeutics AG Stock Soars Amid Strategic Moves
TipRanks · 2d ago
CRISPR Stock Surges in Recent Weeks: What's Going On?
Benzinga · 4d ago
Vertex: Latest Casgevy Data Highlights Efficacy Amid Slow Commercial Launch
Seeking Alpha · 5d ago
Innovation ETF (ARKK) Hits New 52-Week High
NASDAQ · 5d ago
Cathie Wood Makes $5M Biotech Buy, Trims Stake in Roku
TipRanks · 5d ago
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.